JPRN-UMIN000027999
Completed
未知
Risk reducing salpingo-oophorectomy RRSO in BRCA1/2 mutation carriers. - Risk reducing salpingo-oophorectomy RRSO in BRCA1/2 mutation carriers.
agoya university faculty of Medicine0 sites8 target enrollmentSeptember 1, 2017
ConditionsHereditary Breast and Ovarian Cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Hereditary Breast and Ovarian Cancer
- Sponsor
- agoya university faculty of Medicine
- Enrollment
- 8
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Female has active invasive cancer. Female with mental disabilities and who has difficulty to make a determination of therapy. Female during pregnancy and lactation. Femele with active infectional disease. Female who a doctor consider inappropriate Female under 20 years old
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Risk reducing salpingo-oophorectomy in BRCA1/2 mutant carriershereditary breast and ovarian cancerJPRN-UMIN000037086Shimane University Faculty of Medicine50
Not yet recruiting
Not Applicable
Risk-Reducing salpingo-oophorectomy in BRCA1/2 mutant carriersBRCA1/2 mutant carriersJPRN-UMIN000027723Kyoto Prefectural University of Medicine3
Recruiting
Not Applicable
Risk-Reducing salpingo-oopholectomy in BRCA1/2 mutant carriersBRCA1/2 mutant carriersJPRN-UMIN000026299Mie university faculty of Medicine5
Recruiting
Not Applicable
Study on risk reducing salpingo-oophorectomy(RRSO) for BRCA1/2 mutation carriershereditary breast and ovarian cancerJPRN-UMIN000005292Cancer Institute Hospital Department of Gynecology, Breast center, Clinical Genetic Oncology200
Completed
Not Applicable
Evaluation of risk-reducing salpingo-oophorectomy for patients with BRCA 1/2 mutatiohereditary breast and ovarian cancer: HBOCJPRN-UMIN000023606Kindai University Hospital